ProteinQure
Ruby Lin serves as the Business Operations Lead at ProteinQure since January 2022, where responsibilities include managing a $1M+ Research & Development budget, securing $1M in non-dilutive funding, and facilitating key agreements that support scientific initiatives. Previous roles include a Business Development and Strategy Intern position at Trillium Therapeutics Inc., where Ruby conducted competitive intelligence and financial modeling to inform corporate strategy. Academic achievements include an Honours Business Administration degree from Ivey Business School and a Bachelor of Medical Sciences from Western University. Leadership experience spans various roles, including Vice President Education at ALPHA Education, where initiatives focused on historical discourse and community engagement.
ProteinQure
ProteinQure is a revenue-generating software platform for computational protein drug discovery. It combines molecular simulations, machine learning, and quantum computing to do the structure-based design of drugs, solve drug design challenges and deliver new therapeutic candidates.